Compounds containing astatine-211 (211At) can be used in targeted radiotherapies for prostate cancer, but deastatination in the body remains a significant hurdle.
Researchers develop stable compound for targeted alpha therapy in prostate cancer
- Post author:
- Post published:September 3, 2024
- Post category:uncategorized